Last $15.07 USD
Change Today -0.25 / -1.63%
Volume 1.2M
BDSI On Other Exchanges
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David S. Perlin Ph.D.

Member of Scientific Advisory Board, BioDelivery Sciences International, Inc.
AgeTotal Calculated CompensationThis person is connected to 118 board members in 5 different organizations across 5 different industries.

See Board Relationships


Prof. David S. Perlin, Ph.D. has been the President of the Public Health Research Institute (PHRI) since 2005. Dr. Perlin served as a Scientific Director of PHRI from 1992 to 2005. and helped PHRI to emerge as one of the foremost tuberculosis research organizations in the world. He joined PHRI in 1985. He served as a Professor of Microbiology and Molecular Genetics at New Jersey Medical School - UMDJN in 2003. Dr. Perlin served as a Consultant to the US Senate Finance ...

Read Full Background

Corporate Headquarters*

801 Corporate Center Drive
Raleigh, North Carolina 27607

United States

Phone: 919-582-9050
Fax: 919-582-9051

Board Members Memberships*

There is no Board Members Memberships data available.


PhD 1980
Cornell University
BA 1976
Brandeis University
Post-Doctoral Training 1982
Yale University School Of Medicine
Post-Doctoral Training 1985
University of Rochester Medical Center

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BDSI:US $15.07 USD -0.25


Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
Scott Schorer Chief Executive Officer
PlasmaTech Biopharmaceuticals, Inc.
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Mark W. Schwartz Ph.D.Chief Executive Officer, President and Director
Galena Biopharma, Inc.
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIODELIVERY SCIENCES INTL, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at